Press releases

27
Jun 2016
20:30 E.S.T.

MIT Technology Review Names Cellectis on Annual List of 50 Smartest Companies for Second Consecutive Year

Read more
20
Jun 2016
20:30 E.S.T.

Cellectis Announces First Patient Treated in Phase 1 Trial of UCART19 in Pediatric Acute B Lymphoblastic Leukemia (B-ALL)

Read more
19
May 2016
20:30 E.S.T.

Cellectis S.A. Reports Results from Shareholders’ General Meeting Held on May 17, 2016

Read more
11
May 2016
20:30 E.S.T.

Cellectis Reports First Quarter 2016 Financial Results

Read more
2
May 2016
20:30 E.S.T.

Cellectis to Present Data on its Allogeneic CAR T-Cell Programs at the 19th American Society of Gene & Cell Therapy Annual Meeting

Read more
21
Mar 2016
20:30 E.S.T.

Cellectis Announces RetroNectin® Supply and License Agreement with Takara Bio Inc.

Read more
16
Mar 2016
20:30 E.S.T.

Cellectis and MabQuest Announce Immunotherapy Partnership on New Class of PD-1 Antagonist Monoclonal Antibodies

Read more
14
Mar 2016
20:30 E.S.T.

Cellectis Reports Fourth Quarter and Full Year 2015 Financial Results

Read more
8
Mar 2016
21:30 E.S.T.

Cellectis Announces Presentation at the Cowen and Company 36th Annual Health Care Conference in Boston, March 7-9, 2016

Read more
2
Mar 2016
21:30 E.S.T.

Cellectis Subsidiary Calyxt, Acquires Land for New Headquarters Facility

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US